| Metric | შპს სისხლის ბანკი | შპს გენომიქსი |
|---|---|---|
| Growth | ||
| Revenue | ₾1.4m₾3.1m | ₾1.3m₾1.5m |
| Revenue growth | -55.1% | -13.2% |
| Profitability | ||
| EBITDA | ₾29k₾475k | -₾304k-₾249k |
| EBITDA margin | 2.1%15.1% | -22.9%-16.3% |
| Net profit | -₾33k₾317k | -₾277k-₾149k |
| Net margin | -2.3%10.1% | -20.9%-9.8% |
| Balance sheet | ||
| Total assets | ₾1.9m₾2.7m | ₾2.6m₾2.9m |
| Total equity | ₾1.8m₾2.7m | ₾1.2m₾1.5m |
| ROE | -1.8%11.8% | -23.2%-10.1% |